238 results on '"Sawada, K."'
Search Results
2. [Aortic Regurgitation due to Rupture of a Fibrous Strand in Fenestrated Aortic Valve:Report of a Case].
- Author
-
Inagaki M, Koyama Y, Sawada K, and Okawa Y
- Subjects
- Aortic Valve diagnostic imaging, Aortic Valve surgery, Echocardiography, Humans, Middle Aged, Aortic Valve Insufficiency diagnostic imaging, Aortic Valve Insufficiency etiology, Aortic Valve Insufficiency surgery, Heart Valve Prosthesis adverse effects, Heart Valve Prosthesis Implantation adverse effects
- Abstract
Fenestration of the aortic valve cusps rarely causes aortic regurgitation. A 54-year-old woman was diagnosed with aortic regurgitation secondary to a ruptured fibrous strand in a fenestrated aortic valve cusp. Diastolic murmur was pointed out during health checkup five months earlier, and transthoracic echocardiography revealed severe aortic valve regurgitation with a mobile mass attached to the aortic valve cusp. The patient underwent aortic valve replacement. Intraoperatively, we observed a ruptured fibrous strand attached to the non-coronary cusp and cusp laceration, both of which caused severe aortic regurgitation. Histopathological examination of the resected specimen showed myxomatous degeneration. The patient's postoperative course was uneventful, and she was discharged in a stable condition on postoperative day 14.
- Published
- 2022
3. [De novo blast phase of chronic myeloid leukemia with 3q26 abnormality diagnosed by cytogenetic analysis of extramedullary lesion].
- Author
-
Matsunaga T, Naganuma K, Tabayashi T, Kawada T, Sakata N, Takahashi Y, Kimura Y, Anan T, Mitsuhashi T, Kubota Y, Sawada K, Yamashita T, Momose S, Higashi M, Tamaru JI, and Kizaki M
- Subjects
- Female, Humans, Middle Aged, In Situ Hybridization, Fluorescence, Cytogenetic Analysis, Lymph Nodes pathology, Blast Crisis genetics, Blast Crisis pathology, Leukemia, Myelogenous, Chronic, BCR-ABL Positive diagnosis, Leukemia, Myelogenous, Chronic, BCR-ABL Positive genetics, Leukemia, Myelogenous, Chronic, BCR-ABL Positive therapy
- Abstract
A 62-year-old woman was presented at our hospital with visual disturbance. An ocular examination revealed bilateral Roth spots. Laboratory data revealed leukocytosis (236,200 µl) with an excess blast (11%). Physical examination and computed tomography (CT) showed systemic lymphadenopathy. A bone marrow examination revealed a composition of 9.2% blast. Chromosomal analysis on bone marrow cells revealed 46,XX,t (3;12)(q26.2;p13),t (9;22)(q34.1;q11.2) in 80% of metaphases (16/20). Inguinal lymph node biopsy revealed diffuse proliferation of myeloperoxidase (MPO)-positive abnormal cells. Fluorescence in situ hybridization analysis was used to detect the BCR-ABL1 fusion gene and split the signals of MECOM and ETV6. She was diagnosed with de-novo chronic myeloid leukemia (CML) extramedullary blast crisis. She received tyrosine kinase inhibitor (TKI) combination chemotherapy and allogeneic hematopoietic stem cell transplantation and achieved a major molecular response. In this study, we reported a case of CML in blast-phase initially presenting as extramedullary, in which cytogenetic and molecular analyses were useful in the staging method.
- Published
- 2022
- Full Text
- View/download PDF
4. [Leucovorin Administration Allows Continued Pralatrexate Treatment in a Patient with Angioimmunoblastic T-Cell Lymphoma].
- Author
-
Sawada K, Sata H, Yasumi M, and Karasuno T
- Subjects
- Aged, Aminopterin analogs & derivatives, Folic Acid Antagonists, Humans, Leucovorin, Male, Neoplasm Recurrence, Local, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Lymphoma, T-Cell drug therapy
- Abstract
Pralatrexate(PDX)has been approved for the treatment of relapsed/refractory peripheral T-cell lymphoma(PTCL), including angioimmunoblastic T-cell lymphoma(AITL). Oral mucositis is the most common and severe adverse effect of PDX that often leads to dose reduction or omission. Herein, we report a 65-year-old man with AITL, who received PDX treatment after a second relapse. This drug was effective; however, the adverse effects, such as oral mucositis, were severe. Therefore, leucovorin(LV)was administered to prevent the adverse effect, resulting in continuation of the PDX treatment for 8 months. LV administration minimizes adverse effects for patients receiving high-dose methotrexate. However, the optimal dose and schedule of LV in PDX treatment has not yet been established. In the future, clinical trials on the use of LV for PDX-induced oral mucositis are needed.
- Published
- 2020
5. [Results of Multicenter Study on the Accuracy of CT Imaging Dose and Quantitative Analysis of SPECT/CT and PET/CT].
- Author
-
Iimori T, Shohji T, Miwa K, Sawada K, Ishiguro M, Sekimoto M, Suda M, Matsubara K, and Tsushima H
- Subjects
- Radiopharmaceuticals, Positron Emission Tomography Computed Tomography, Single Photon Emission Computed Tomography Computed Tomography
- Published
- 2019
- Full Text
- View/download PDF
6. [A Resected Case of Cancer in the Ileum of the Blind Loop after an Ileotransverse Colostomy].
- Author
-
Yasuyama A, Saijo F, Matsumura N, Narushima Y, Takahashi KI, Akada M, Nomura R, Haneda S, Muto M, Yasumoto A, Sawada K, Chitose H, Sato K, and Tokumura H
- Subjects
- Aged, 80 and over, Appendectomy, Colostomy, Humans, Ileum, Male, Adenocarcinoma diagnosis, Adenocarcinoma surgery, Appendicitis surgery, Intestinal Neoplasms diagnosis, Intestinal Neoplasms surgery
- Abstract
We report a resected case of cancer at the ileum of the blind loop. An 81-year-old male underwent an appendectomy for acute appendicitis and an ileotransverse colostomy for postoperative obstruction when he was 14 years old. He underwent radiation therapy for prostate cancer when he was 75 years old. Six years later, enhanced computed tomography revealed a 7 cm mass in the ileum of the blind loop. Colonoscopy showed wall thickening at the ileum of the blind loop, and biopsy revealed an adenocarcinoma. We performed partial resection of the ileum. The patient was discharged 17 days after surgery. Cancer at the ileum of the blind loop after an ileotransverse colostomy has rarely been reported.
- Published
- 2018
7. [Analysis of Non-serotype b Encapsulated Haemophilus influenzae Isolated from Pediatric Patients].
- Author
-
Kutsuna S, Hoshino T, Fukasawa C, Tokutake S, Okui H, Sawada K, Sato H, Takahashi Y, and Ishiwada N
- Subjects
- Bacterial Capsules, Child, Child, Preschool, Drug Resistance, Bacterial, Haemophilus influenzae drug effects, Humans, Infant, Serogroup, Haemophilus influenzae isolation & purification
- Abstract
We analyzed non-serotype b encapsulated Haemophilus influenzae (non-b Hi) isolated from pediatric patients at Chiba Children's Hospital during 2000-2012. Among 3,532 clinical isolates of H. influenzae, there were 57 (1.6%) strains of non-b Hi, 152 (4.3%) of serotype b H. influenzae (Hib), and 3,323 (94.1%) of non-typeable H. influenzae (NTHi). Fifty-seven strains of non-b Hi were serotyped useing the slide agglutination test and PCR. Twenty-nine strains were identified as type e (Hie) and 28 as type f (Hif), and the results according to the slide agglutination test and PCR were completely identical. Whereas 52 of 57 strains (91.2%) were isolated from respiratory specimen, only one Hif strain (1.8%) was isolated from a sterile site. There were 47 (82.4%) β-lactamase-non-producing ampicillin (ABPC)-sensitive strains (BLNAS), 5 (8.8%) β-lactamase-producing strains (BLP), and only 1 (1.8%) β-lactamase-non-producing ABPC-resistant strain (BLNAR). Thus the frequency of non-b Hi was lower than that of Hib. The source of non-b Hi was similar to that of NTHi, which was mainly isolated from respiratory specimen. Antimicrobial resistant pattern of non-b Hi was different from that of Hib in which the frequency of BLP was relatively high, and NTHi in which that of BLNAR was high. An increase of invasive H. influenzae infections caused by NTHi, Hie, and Hif was reported in the countries where Hib vaccine had been widely used. Because it is assumed that invasive non-Hib infection will be predominant in the near future in Japan, serotyping of invasive strains is crucial. Continuous monitoring of distribution of non-b Hi in the clinical isolates of H. influenzae is also important.
- Published
- 2015
- Full Text
- View/download PDF
8. [Complete resection of liver metastases of colorectal cancer after high efficacy bevacizumab, S-1, and CPT -11 combination chemotherapy].
- Author
-
Imai H, Sawada K, Sato A, Nishi K, Sasaki T, Takahashi T, and Ohori H
- Subjects
- Adenocarcinoma drug therapy, Aged, Antibodies, Monoclonal, Humanized administration & dosage, Bevacizumab, Camptothecin administration & dosage, Camptothecin analogs & derivatives, Combined Modality Therapy, Drug Combinations, Humans, Irinotecan, Liver Neoplasms secondary, Liver Neoplasms surgery, Male, Oxonic Acid administration & dosage, Sigmoid Neoplasms drug therapy, Sigmoid Neoplasms surgery, Tegafur administration & dosage, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Liver Neoplasms drug therapy, Sigmoid Neoplasms pathology
- Abstract
We describe a case of liver metastasis of colorectal cancer that became resectable after bevacizumab (Bmab), CPT-11, and S-1 ie Bmab+IRIS combination chemotherapy. A 65-year-old man experienced repeated constipation and diarrhea in August of 2013. Colonoscopy was conducted by a local doctor, and a tumor(diagnosed as adenocarcinoma tub1 by biopsy)was found in the upper rectum. Computed tomography performed at our institution detected synchronous liver metastasis. On September 9, laparoscopic rectal anterior resection was performed to prevent metastasis to the ileus, and on October 9, the patient began receiving Bmab+IRIS combination chemotherapy. Before chemotherapy, 3 metastases with a maximum diameter of 7 cm diameter)were observed in the right lobe of the liver. After 4 courses of chemotherapy, their maximum diameter was 3 cm, which allowed resection. Ultimately, the metastases were completely resected. Conversion of non optimal resection cases of liver metastases to optimal cases by using Bmab+IRIS chemotherapy is extremely rare. We suggest that Bmab+IRIS chemotherapy could be an option for conversion of non optimal liver resection cases to optimal cases. We report this rare case and discuss the implications of adjuvant chemotherapy for this patient.
- Published
- 2015
9. [New Developments in CKD-MBD. Cell Biology of parathyroid in CKD].
- Author
-
Kakuta T and Sawada K
- Subjects
- Apoptosis, Bone Diseases, Metabolic etiology, Humans, Parathyroid Diseases pathology, Renal Insufficiency, Chronic complications, Renal Insufficiency, Chronic drug therapy, Bone Diseases, Metabolic metabolism, Parathyroid Diseases metabolism, Parathyroid Hormone metabolism, Renal Insufficiency, Chronic metabolism
- Abstract
Parathyroid monitors the calcium concentration in blood by signals from calcium-sensing receptors, adjusts secretion of parathyroid hormone to keep constant calcium concentration in the body. Although parathyroid parenchymal cells consist of chief cells which secrete PTH, and oxyphil cells which are rich in mitochondria, all hardly perform mitotic proliferation in normal status. However, in CKD, PTH hypersecretion and hyperplasia are started by hyperphosphatemia, hypocalcemia, and activated-vitamin-D deficiency, and the secondary hyperparathyroidism develops. While treatment with cinacalcet hydrochloride salt induced apoptosis into the parathyroid cell, a possibility of promoting the transdifferentiation to oxyphil cells from chief cells was suggested. The specific accumulation to the parathyroid of an oncotropic photosensitizer suggests the possibility of photodynamic diagnosis and treatment of hyperparathyroidism.
- Published
- 2014
- Full Text
- View/download PDF
10. [Clinical impact of addition of bevacizumab to the first-line chemotherapy regimen in the treatment of patients with metastatic colorectal cancer].
- Author
-
Sogabe S, Tateno T, Yagisawa M, Ishikawa M, Sawada K, Muranaka T, Umemura M, Kato R, Takasaka T, Takahashi K, Dazai M, Iwanaga I, Oda H, and Miyagishima T
- Subjects
- Adult, Aged, Aged, 80 and over, Bevacizumab, Colorectal Neoplasms pathology, Disease Progression, Female, Humans, Male, Middle Aged, Neoplasm Metastasis, Retrospective Studies, Antibodies, Monoclonal, Humanized administration & dosage, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Colorectal Neoplasms drug therapy
- Abstract
Background: Combination regimens containing bevacizumab(BV)are regarded as one of the standard first-line chemotherapy (1stCTx) regimens in the treatment of metastatic colorectal cancer (mCRC). However, some patients cannot be treated with BV because of the short interval from the palliative operation or other reasons. We present a study of some patients who were treated with add-on BV in the middle of the 1stCTx before disease progression(referred to as "midway BV" regimen hereafter), and here, we report the efficacy of the midway BV regimen as observed in our patients., Results: We retrospectively analyzed the data of 74 mCRC patients, who were undergoing 1stCTx treatment at our hospital from January 2010 to September 2012. We divided the patients into 3 groups, depending on when BV was introduced in their regimen: 40, 25, and 9 patients were respectively included in the "no-BV" group (patients who were treated without BV in the 1stCTx), BV group(patients treated with BV from the 1st cycle in the 1stCTx), and the midway-BV group (patients who were initially treated without BV and then received add-on BV). The response rates of patients in the no-BV, BV, and midway-BV groups were 27.5%, 44.0%, and 55.6%, respectively. The median progression-free survival (PFS) and median survival time of patients in the no-BV, BV, and midway-BV groups were, respectively, 9.7 months, 9.3 months, and 12.8 months, and 20.3 months, 22.2 months, and N. R., Conclusion: Although few cases were analyzed and there might be many confounding factors, our study suggests that midway BV is potentially useful for patients with metastatic colorectal cancer who are not initially treated with BV in the first cycle of the 1stCTx regimen.
- Published
- 2014
11. [Case report; A case of Fanconi's syndrome with pathological ulnar fractures improved by dose reduction of adefovir and supplementation of oral phosphate].
- Author
-
Utsumi T, Sawada K, Nakajima S, Abe M, Ohtake T, Fujiya M, and Kohgo Y
- Subjects
- Adenine administration & dosage, Adenine adverse effects, Administration, Oral, Aged, Antiviral Agents adverse effects, Female, Hepatitis B drug therapy, Humans, Organophosphonates administration & dosage, Adenine analogs & derivatives, Antiviral Agents administration & dosage, Fanconi Syndrome chemically induced, Fractures, Spontaneous etiology, Organophosphonates adverse effects, Phosphates administration & dosage, Ulna injuries
- Published
- 2014
- Full Text
- View/download PDF
12. [Case report; myeloid sarcoma with systemic lymphadenopathy, skin and gastrointestinal infiltration].
- Author
-
Ishikawa M, Miyagishima T, Sawada K, Muranaka T, Umemura M, Kato R, Takasaka T, Takahashi K, Sogabe S, and Oda H
- Subjects
- Aged, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Cytarabine therapeutic use, Daunorubicin therapeutic use, Gastrointestinal Neoplasms pathology, Humans, Lymphatic Diseases complications, Lymphatic Diseases diagnosis, Male, Neoplasm Invasiveness, Sarcoma, Myeloid complications, Sarcoma, Myeloid diagnosis, Skin Neoplasms pathology, Gastrointestinal Neoplasms drug therapy, Lymphatic Diseases drug therapy, Sarcoma, Myeloid drug therapy, Skin Neoplasms drug therapy
- Published
- 2014
- Full Text
- View/download PDF
13. [Concentration of tazobactam/piperacillin in the cerebrospinal fluid of patients with Haemophilus influenzae type B meningitis].
- Author
-
Fukasawa C, Hoshino T, Kutsuna S, Sawada K, Sato H, and Ishiwada N
- Subjects
- Anti-Bacterial Agents administration & dosage, Child, Preschool, Drug Therapy, Combination methods, Female, Humans, Male, Meningitis, Haemophilus drug therapy, Microbial Sensitivity Tests, Penicillanic Acid cerebrospinal fluid, Piperacillin cerebrospinal fluid, Piperacillin, Tazobactam Drug Combination, Treatment Outcome, Anti-Bacterial Agents therapeutic use, Meningitis, Haemophilus cerebrospinal fluid, Penicillanic Acid analogs & derivatives
- Abstract
While the incidence of Haemophilus influenzae type b (Hib) meningitis is expected to decrease with the widespread use of the Hib vaccine, the resistance of Hib has actually increased. Therefore, selection of the initial antibiotics used for treatment must be performed with resistant bacteria, including beta-lactamase negative ampicillin resistant H. influenzae (BLNAR), in mind. Tazobactam/piperacillin (TAZ/PIPC) has a satisfactory minimum inhibitory concentration (MIC) against BLNAR and is a beta-lactamase inhibitor. Although there is no insurance coverage for its use in patients with meningitis, the penetration of TAZ/PIPC into cerebrospinal fluid (CSF) in animal experiments promises a satisfactory result, and we have been using a combination of ceftriaxone (CTRX) and TAZ/PIPC as an initial treatment and a resistant bacteria countermeasure in patients with Hib meningitis at our hospital since 2008. We examined the concentration of TAZ/PIPC in CSF to further investigate the possibility of using TAZ/PIPC as an antibiotic treatment against bacterial meningitis. In cases treated with a 1: 8 drug formulation of TAZ/PIPC against Hib meningitis at our hospital, we used the remaining portion of a CSF sample collected after the initiation of TAZ/PIPC administration and then measured the concentrations of TAZ and PIPC in the CSF. Six specimens from 5 patients between the ages of 6 and 59 months were examined. The dosage of TAZ/PIPC was 95.7-113.6 mg/kg/dose x 3 times/day, and the CSF concentrations at 0-105 minutes after the completion of the administration were 0.319-1.32 microg/mL for TAZ and 2.54-7.74 microg/mL for PIPC. With the approved dosage, the peak concentration level during the acute period indicated a sufficient CSF concentration level for the antibacterial and beta-lactamase inhibition effects against Hib. As an antibiotic treatment for H. influenzae meningitis, the combined usage of TAZ/PIPC is likely to be effective as a resistant bacteria countermeasure, in addition to third-generation cephem drugs and meropenem.
- Published
- 2013
- Full Text
- View/download PDF
14. [Antimicrobial susceptibility of Haemophilus influenzae isolated from pediatric patients at a pediatric facility between 2009 and 2012].
- Author
-
Hoshino T, Kutsuna S, Sawada K, Sato H, and Fukasawa C
- Subjects
- Child, Child, Preschool, Disease Susceptibility, Female, Humans, Infant, Japan, Male, Serotyping methods, Treatment Outcome, Anti-Bacterial Agents therapeutic use, Haemophilus Infections drug therapy, Haemophilus influenzae isolation & purification
- Abstract
We examined the antimicrobial susceptibility of 1,208 Haemophilus influenzae isolates obtained at a pediatric facility between 2009 and 2012. The percentage distribution of beta-lactamase-non-producing ampicillin (ABPC)-sensitive (BLNAS) strains was 38.2%, that of beta-lactamase-non-producing ABPC-intermediately resistant (BLNAI) strains was 13.9%, that of beta-lactamase-non-producing ABPC-resistant (BLNAR) strains was 38.2%, that of beta-lactamase-producing ABPC-resistant (BLPAR) strains was 5.2%, and that of beta-lactamase-producing clavulanic acid/amoxicillin-resistant (BLPACR) strains was 4.5%. Although the percentage of BLNAR strains increased dramatically from 13.9% (2000-2003; period I) to 32.7% (2004-2008; period II), it increased more slowly from period II to the present period (2009-2012). However, the percentage of BLNAI strains, which had decreased from 10.6% (period I) to 8.9% (period II), began to increase during the present period. Tosufloxacin (< or = 0.06 microg/mL) and tazobactam/piperacillin (< or = 0.13 microg/mL) exhibited a low 90% minimum inhibitory concentration for H. influenzae, as well as for BLNAR strains. A decreased susceptibility to cephems was also observed throughout all 3 periods. Serotype b strains (Hib) were observed in 54 of the 1,208 isolates (4.5%); their distribution decreased since period II (6.3%). In Hib, the percentage distribution of strains from patients less than 2 years of age, who are recommended to be vaccinated against Hib, decreased from 56.8% to 29.6%, and this reduction seems to have been achieved by increasing the percentage of Hib vaccine inoculations in Japan. Non-serotype b-capsulated strains were identified in 21 isolates (1.7%), and 11 of them were serotyped as type e, whereas the other 10 were serotyped as type f.
- Published
- 2013
- Full Text
- View/download PDF
15. [Erythropoiesis and enucleation].
- Author
-
Ubukawa K and Sawada K
- Subjects
- Animals, Cell Differentiation physiology, Cell Division physiology, Humans, Induced Pluripotent Stem Cells cytology, Cell Nucleus metabolism, Erythroblasts cytology, Erythropoiesis physiology
- Published
- 2013
16. [Successful treatment of an HIV-positive multiple myeloma patient with high-dose chemotherapy followed by autologous peripheral blood stem cell transplantation and maintenance therapy with lenalidomide].
- Author
-
Miyagishima T, Tateno T, Kasahara KH, Sawada K, Sogabe S, and Oda H
- Subjects
- Humans, Lenalidomide, Male, Middle Aged, Multiple Myeloma diagnosis, Multiple Myeloma pathology, Thalidomide therapeutic use, Transplantation, Autologous methods, Treatment Outcome, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Multiple Myeloma therapy, Peripheral Blood Stem Cell Transplantation methods, Thalidomide analogs & derivatives
- Abstract
A 45-year-old HIV positive male who had previously been administered anti-retrovirus therapy (ART) resulting in a good virological response and with a CD4 count of more than 1,000/μl, complained of general fatigue during a periodic examination. Laboratory data showed decreased Hb (10.8 g/dl) and increased T.P (12.0 g/dl) and IgG (9,077 mg/dl). Monoclonal gammopathy (IgG-λ) was identified and bone marrow aspiration revealed 37.6% atypical plasma cells, leading to the diagnosis of symptomatic multiple myeloma (MM) (ISS clinical staging III).Four courses of VD (bortezomib+dexamethasone) therapy were administered with concurrent ART resulting in VGPR (very good partial response), followed by peripheral blood stem cell collection (the mobilizing chemotherapy was cyclophosphamide). Then, together with ART, high-dose chemotherapy (Mel-200; L-PAM) was administered with autologous peripheral blood stem cell transplantation (PBSCT). Reconstitution of white blood cells was achieved at 10 days after PBSCT. There were no adverse effects of ART and the viral load of HIV was well controlled during the period of these treatments. The final assessment was VGPR and 10 mg/day of lenalidomide has since been administered as maintenance therapy. Standard treatment combined with PBSCT for juvenile-onset MM is also effective and safe for HIV-positive patients receiving ART.
- Published
- 2013
17. [Case report; differential diagnosis of post-transfusion graft-versus-host disease in a case with toxic epidermal necrolysis].
- Author
-
Ohyagi H, Kume M, Takahashi N, and Sawada K
- Subjects
- Aged, 80 and over, Fatal Outcome, Female, Humans, Stevens-Johnson Syndrome etiology, Diagnosis, Differential, Graft vs Host Disease complications, Graft vs Host Disease diagnosis, Skin pathology, Stevens-Johnson Syndrome diagnosis
- Published
- 2013
- Full Text
- View/download PDF
18. [A case of tuberculous peritonitis in a hemodialysis patient revealed by severe diarrhea and stomachache].
- Author
-
Hara M, Hatta T, Ohtani M, Segawa H, Ueno R, and Sawada K
- Subjects
- Biomarkers blood, CA-125 Antigen blood, Diagnosis, Differential, Drug Combinations, Female, Humans, Middle Aged, Peritonitis, Tuberculous complications, Peritonitis, Tuberculous pathology, Receptors, Interleukin-2 blood, Renal Dialysis methods, Treatment Outcome, Abdominal Pain complications, Antitubercular Agents therapeutic use, Diarrhea complications, Ethambutol therapeutic use, Isoniazid therapeutic use, Peritonitis, Tuberculous diagnosis, Peritonitis, Tuberculous drug therapy, Pyrazinamide therapeutic use, Rifampin therapeutic use
- Abstract
A 53-year-old woman was admitted to our hospital due to abdominal pain, diarrhea, and shunt occlusion caused by dehydration. She had undergone hemodialysis due to diabetic nephropathy over a ten-year period. She was hospitalized again with fever and a persistent high serum CRP level. We started antibiotic administration using cefotiam hexetil hydrochloride because of ascites and peritoneum thickening observed by abdominal computed tomography. Although her symptoms, such as abdominal pain and diarrhea, improved after the administration of antibiotics, the ascites and the peritoneum thickening did not improve. On the fourth hospital day, we attempted ascites aspiration to investigate the etiology of the peritonitis. Cytological examination suggested tuberculous peritonitis because of predominant macrophage cell proliferation, a high level of ADA concentration, and a high level of CA125 of ascites. Although QuantiFERON-tuberculosis (QFT) and the Gaffky scale were negative, we started multidrug therapy (isoniazid + rifampicin + pyrazinamide + ethambutol) on the 20th hospital day. She was finally diagnosed as mycobacterium tuberculous peritonitis based on biopsy of the tissue of the ileum and the results of colonoscopy. Administration of antituberculosis chemotherapy improved abdominal fullness and ascites and the patient was discharged on the 97th hospital day. Moreover Kuno et al. reported that serum soluble interleukin-2 receptor(sIL-2R) and CA-125 levels can be used to monitor the response to anti-tuberculosis treatment. In this case, we use these markers to monitor the response to treatment. We experienced a case of tuberculous peritonitis undergoing hemodialysis. Tuberculosis should be suspected when patients undergoing dialysis have long-term fever of unknown etiology. There are many reports stating that the sensitivity and specificity of QuantiFERON-tuberculosis (QFT) and sputum culture are low in latent tuberculosis infection of dialysis patients. Accordingly it is necessary to diagnose mycobacterium tuberculous peritonitis comprehensively by the clinical symptoms and image analysis.
- Published
- 2013
19. [Effect of an educational admission program for patients at the conservative phase of chronic kidney disease (CKD)].
- Author
-
Ueno R, Hatta T, Kawasaki Y, Hara M, Otani M, Segawa H, Maki K, and Sawada K
- Subjects
- Diabetic Nephropathies diagnosis, Diabetic Nephropathies therapy, Disease Progression, Humans, Renal Insufficiency, Chronic diagnosis, Retrospective Studies, Risk Assessment, Treatment Outcome, Patient Education as Topic, Renal Insufficiency, Chronic therapy
- Abstract
Purpose: We have been conducting a 1-week educational admission program for patients at the conservative phase of chronic kidney disease (CKD) since 2006. In this study we evaluated the effect of the program., Methods: We retrospectively reviewed 469 patients who could be followed for 12 months after a 1-week educational admission program for CKD out of a total of 700 patients who attended the program between October 2006 and April 2012. We compared the rates of decrease in renal function before and after the program. In addition, we divided the patients into two groups of diabetic nephropathy and non-diabetic nephropathy. We compared the rate of decrease in renal function in each group., Results: The rate of decrease in renal function 12 months after discharge was improved compared with that 6 months before admission. (before: 0.316 mL/min/1.73 m2/month; after: 0.001 mL/min/1.73 m2/month.) The rate of decrease in renal function 6 months before admission of the diabetic nephropathy group was 72.3 times faster than that of the non-diabetic nephropathy group. However, the rate of decrease in renal function 12 months after admission was improved in both groups., Conclusion: It was revealed that the educational admission program is effective for preserving the renal function on patients at the conservative phase of CKD.
- Published
- 2013
20. [Adult T-cell leukemia-lymphoma developed from an HTLV-1 carrier during treatment of B-cell lymphoma-associated hemophagocytic syndrome].
- Author
-
Nagao T, Takahashi N, Saitoh H, Noguchi S, Guo YM, Ito M, Watanabe A, Fujishima N, Kameoka Y, Tagawa H, Hirokawa M, and Sawada K
- Subjects
- Antibodies, Monoclonal, Murine-Derived, Antineoplastic Combined Chemotherapy Protocols, Cyclophosphamide, Doxorubicin, Female, Humans, Leukemia-Lymphoma, Adult T-Cell virology, Lymphohistiocytosis, Hemophagocytic complications, Lymphohistiocytosis, Hemophagocytic diagnosis, Lymphoma, B-Cell complications, Middle Aged, Prednisone, Rituximab, Treatment Outcome, Vincristine, Human T-lymphotropic virus 1, Leukemia-Lymphoma, Adult T-Cell therapy, Lymphohistiocytosis, Hemophagocytic drug therapy, Lymphoma, B-Cell therapy
- Abstract
A 63-year-old woman was admitted to our hospital with high-grade fever, liver dysfunction, and pancytopenia. Computed tomography of the whole body revealed hepatosplenomegaly but no lymphoadenopaties. Bone marrow aspiration showed infiltrations of CD20-positive large atypical B-lymphocytes with severe hemophagocytosis. Although she was a human T-cell leukemia virus type 1 carrier, the atypical lymphocyte in bone marrow had IgH rearrangement but not TCR rearrangement. From these clinical and laboratory data, the patient was diagnosed as having B-cell lymphoma-associated hemophagocytic syndrome (B-LAHS) and treated with R-CHOP chemotherapy (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone). After 4 cycles of R-CHOP, she had achieved complete remission. However, increased numbers of CD4+CD25+ flower cells were observed in peripheral blood and HTLV-1 provirus DNA was detected after 5 cycle of R-CHOP. The patient was diagnosed as adult T-cell leukemia-lymphoma (ATL) complicated by B-LAHS. Our observations suggest that continuous immunosuppressive statement for B-cell lymphoma or the chemotherapy against B-LAHS may induce the development of ATL in an HTLV-1 carrier.
- Published
- 2012
21. [Case report; Fibrinoid necrotizing angiitis of the gall bladder in a patient with systemic lupus erythematosus].
- Author
-
Ikeda S, Komatsuda A, Togashi M, Yamashita T, Michishita Y, Fujishima M, Fujishima N, Wakui H, and Sawada K
- Subjects
- Adult, Female, Gallbladder Diseases pathology, Humans, Polyarteritis Nodosa pathology, Gallbladder Diseases etiology, Lupus Erythematosus, Systemic complications, Polyarteritis Nodosa etiology
- Published
- 2012
- Full Text
- View/download PDF
22. [Bone marrow failure syndrome (idiopathic hematopoietic disorders): progress in diagnosis and treatment. Topics: IV. Recent topics of hematopoiesis; 2. The mechanism of erythroblasts enucleation].
- Author
-
Ubukawa K and Sawada K
- Subjects
- Anemia, Aplastic, Animals, Bone Marrow Diseases, Bone Marrow Failure Disorders, Cell Nucleus, Erythrocytes metabolism, Humans, Macrophages cytology, Erythroblasts cytology, Erythrocytes cytology, Hematopoiesis physiology, Hemoglobinuria, Paroxysmal diagnosis, Hemoglobinuria, Paroxysmal therapy
- Published
- 2012
- Full Text
- View/download PDF
23. [Bone marrow failure syndrome (idiopathic hematopoietic disorders): progress in diagnosis and treatment. Recent topics in bone marrow failure syndrome].
- Author
-
Sawada K
- Subjects
- Anemia, Aplastic, Bone Marrow Diseases, Bone Marrow Failure Disorders, Bone Marrow Transplantation, Hematopoiesis, Hemoglobinuria, Paroxysmal immunology, Humans, Hemoglobinuria, Paroxysmal diagnosis, Hemoglobinuria, Paroxysmal therapy, Practice Guidelines as Topic
- Published
- 2012
- Full Text
- View/download PDF
24. [Bone marrow failure syndrome (idiopathic hematopoietic disorders): progress in diagnosis and treatment. Topics: III. Diagnosis and treatments 2, Pure red cell aplasia].
- Author
-
Hirokawa M and Sawada K
- Subjects
- Anemia, Aplastic, Bone Marrow Diseases, Bone Marrow Failure Disorders, Humans, Immunosuppression Therapy, Lymphocytosis immunology, Prognosis, Red-Cell Aplasia, Pure etiology, Red-Cell Aplasia, Pure immunology, Hemoglobinuria, Paroxysmal diagnosis, Hemoglobinuria, Paroxysmal therapy, Red-Cell Aplasia, Pure diagnosis, Red-Cell Aplasia, Pure therapy
- Published
- 2012
- Full Text
- View/download PDF
25. [Regulation of erythropoiesis by microbial nucleic acid].
- Author
-
Guo YM and Sawada K
- Subjects
- Animals, Humans, Ligands, Mice, Toll-Like Receptor 9, Cell Differentiation genetics, Erythroblasts cytology, Erythropoiesis genetics, Nucleic Acids physiology, Oligodeoxyribonucleotides genetics, Parvovirus B19, Human genetics
- Published
- 2012
26. [Case of lupus nephritis complicated with hemophagocytic syndrome].
- Author
-
Ueno R, Kado H, Shiotsu Y, Hara M, Otani M, Segawa H, Sawada K, and Hatta T
- Subjects
- Adult, Diagnosis, Differential, Female, Ferritins blood, Humans, Hypercholesterolemia etiology, L-Lactate Dehydrogenase blood, Lupus Nephritis diagnosis, Pancytopenia etiology, Proteinuria drug therapy, Proteinuria etiology, Lupus Nephritis drug therapy, Lymphohistiocytosis, Hemophagocytic diagnosis, Lymphohistiocytosis, Hemophagocytic etiology
- Abstract
A 27-year-old woman was referred to our hospital because of pancytopenia and nephritic syndrome in November, 2008. The findings of physical and laboratory examinations showed systemic lupus erythematosus (SLE). Diffuse proliferative lupus nephritis(group IV-G(A))was confirmed by renal biopsy. After combined therapy with prednisolone, intravenous cyclophosphamide pulse and mizoribine, proteinuria decreased from 13.0 g/day to 2.0 g/day and the serum complement level recovered to the normal level. However, she visited our hospital again for management of bleeding tendency in July 2009. She was diagnosed as hemophagocytic syndrome (HPS), with pancytopenia, high ferritin, high LDH level and hemophagocytosis in the bone marrow. She was treated effectively with steroid pulse therapy, but relapsed with HPS after two weeks. Although her child caught a cold, the case did not show any sign or symptom of infection, such as the common cold. However, we diagnosed her HPS as infection-associated hemophagocytic syndrome (IAHS) because she was not in the active phase of SLE at the onset of hemophagocytosis and the laboratory findings showed elevation of her serum ferritin and LDH. Therefore, we considered that her infectious sign may have been concealed by immunosuppressive therapy with prednisolone for SLE. It is very difficult to distinguish between IAHS and autoimmune-associated hemophagocytic syndrome (AAHS)in autoimmune diseases, but the differential diagnosis is necessary to treat the HPS. Here, we report an important case of HPS complicated with SLE. This case may attract interest particularly in the management of HPS-complicated autoimmune disease. Therefore, we report it with a review of the literature.
- Published
- 2012
27. [A case of androgen insensitivity syndrome (AIS) treated by Laparoendoscopic single site surgery (LESS)].
- Author
-
Kishimoto N, Okumi M, Miyagawa Y, Yoshioka I, Sawada K, Kimura T, and Nonomura N
- Subjects
- Female, Humans, Male, Neoplasms, Germ Cell and Embryonal pathology, Testicular Neoplasms pathology, Young Adult, Androgen-Insensitivity Syndrome surgery, Laparoscopy methods
- Abstract
A 20-year-old woman referred to our hospital for further examination of primary amenorrhea with high levels of testosterone (998 ng/ml). Inspite of having normal female external genitalia, she had 5 cm deep blind-ending vagina, absence of uterus and ovaries with the karyotype of 46,XY. Abdominal magnetic resonance imaging localized bilateral intra abdominal structures, which indicated bilateral testes. Thus, she was diagnosed with androgen insensitivity syndrome(AIS) based on both clinical and karyotypic evidence. She underwent laparoscopic bilateral gonadalectomy through a single incision at the navel and histological examination showed intratubular germ cell neoplasia (ITGCN). Her postoperative course was uneventful with less pain and a small surgical wound was only at the navel. Laparoendoscopic single site surgery (LESS) can be considered a surgical procedure for gonadalectomy in AIS patients.
- Published
- 2011
28. [Type 4 advanced gastric cancer responding to histological complete response after neoadjuvant S-1 combined with CDDP therapy-report of a case].
- Author
-
Asaumi Y, Miyanaga T, Ito H, Sawada K, Fujita M, Miyazaki M, Yagi D, Kitamura H, Hirano M, Maeda K, Hayashida Y, Ohta K, Hayashi H, Doden K, Hattori M, Hashizume Y, and Kaizaki Y
- Subjects
- Aged, Cisplatin administration & dosage, Drug Combinations, Humans, Male, Oxonic Acid administration & dosage, Stomach Neoplasms pathology, Stomach Neoplasms surgery, Tegafur administration & dosage, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Cisplatin therapeutic use, Neoadjuvant Therapy, Oxonic Acid therapeutic use, Stomach Neoplasms drug therapy, Tegafur therapeutic use
- Abstract
A 75-year-old man with type 4 advanced gastric cancer was referred to our hospital. We diagnosed the tumor as cStage III B(cT4a, cN2, cM0)gastric cancer. We selected neoadjuvant S-1 combined with CDDP therapy for him. After 2 courses of chemotherapy, the extension of the gastric wall improved. After an additional 2 courses of chemotherapy, the primary tumor revealed a partial response(PR), judged from a barium meal study and upper GI endoscopic findings, and a total gastrectomy with lymph node dissection was performed. The pathological specimens showed no cancer cells in the gastric wall and lymph nodes, so the histological effect was judged as Grade 3.
- Published
- 2011
29. [Discrimination thresholds for recognizing facial emotions: mostly higher among the elderly].
- Author
-
Kumada M, Yoshida H, Hashimoto Y, Sawada K, Maruishi M, and Miyatani M
- Subjects
- Age Factors, Aged, Expressed Emotion, Female, Humans, Male, Sensory Thresholds, Young Adult, Discrimination, Psychological, Emotions, Facial Expression
- Abstract
Elderly people have lower ability for recognizing facial emotions than younger people. Previous studies showed that older adults had difficulty in recognizing anger, sadness and fear, but there were no consistent results for happiness, surprise and disgust. Most of these studies used a small number of stimuli, and tabulated the number of correct responses for facial expressions. These characteristics of the task might be the source of the discrepancy in the findings. The present study used a task which measures participants' discrimination thresholds for six basic emotions using psychophysical measurement methods. The results showed that the thresholds for elderly participants (74.8 +/- 6.5 yrs) were significantly higher than for younger participants (20.1 +/- 1.6 yrs) for sadness, surprise, anger, disgust and fear. There was no significant difference for happiness. Since the task that we developed was sufficiently sensitive, it is a useful tool for assessing individuals' ability to perceive emotion.
- Published
- 2011
- Full Text
- View/download PDF
30. [Antimicrobial susceptibility and serotype distribution in perinatal group B Streptococcus isolates--a 1999-2009 multicenter study].
- Author
-
Wakimoto H, Wakimoto Y, Yano H, Matsubara K, Miyakawa S, Yoshida A, Okuzumi K, Sato H, Sawada K, Yamada Y, Futamura M, Kitagawa M, Sato T, Minami M, and Hasegawa T
- Subjects
- Female, Humans, Infant, Newborn, Microbial Sensitivity Tests, Penicillins pharmacology, Pregnancy, Serotyping, Streptococcus agalactiae classification, Streptococcus agalactiae drug effects
- Abstract
We determined temporary changes in group B Streptococcus antimicrobial susceptibility and serotype distribution from perinatal strains. We examined invasive microbiological isolates from neonates with early-onset group B streptococcal disease (n = 14), and colonized isolates from those born uneventfully (n = 55) and from the genital tracts of pregnant and puerperal women (n = 198), collected between 1999 and 2009. All isolates were susceptible to penicillin. No significant differences were seen in susceptibility of 12 antimicrobial agents examined between invasive and colonized isolates. MIC50, MIC90, and resistance did not differ between stage I (1999-2005) and II (2006-2009) isolates. Serotype distribution significantly differed, however, serotypes III and Ia predominated among invasive isolates, while serotypes Ib and VI were common among their colonized counterparts. These findings suggest that to date, penicillin remains effective in intrapartum prophylactic use in colonized pregnant women.
- Published
- 2011
- Full Text
- View/download PDF
31. [Case of fanconi syndrome positive for anti-M2 antibodies revealed by severe hypokalemia and multiple bone fracture].
- Author
-
Hara M, Miyazawa R, Takagi A, Kado H, Maki K, Sawada K, You K, and Hatta T
- Subjects
- Adult, Female, Humans, Liver Cirrhosis, Biliary, Severity of Illness Index, Autoantibodies, Fanconi Syndrome complications, Fanconi Syndrome immunology, Fractures, Bone etiology, Hypokalemia etiology, Mitochondria immunology
- Abstract
A 38-year-old female developed pain in the right leg in 2006. In 2007, the diagnosis of femoral head necrosis was made based on MR images, and femoral head prosthetic replacement was performed. In April 2009, she visited a local hospital for low back pain, and was referred to our department due to electrolyte abnormalities on hemanalysis. Since marked hypokalemia (K=2.5 mEq/L), hypophosphatemia, hyperchloric metabolic acidosis, proteinuria, and urinary blood sugar suggested Fanconi syndrome, she was admitted for close examination. Bone survey showed a marked decrease in the amount of bone particularly in the four limbs and fracture at the proximal 1/3 of the left ulnar bone. In the lumbar spine, scoliosis and vertebral deformity were observed. Since impaired P re-absorption and unselected aminoaciduria and osteomalacia were also present, the diagnosis of Fanconi syndrome was made. On admission, ventricular tachycardia developed due to hypokalemia, requiring immediate electrolyte correction. For differentiation from acquired Fanconi syndrome, various examinations were performed. No apparent cause was found except for the positive antimitochondrial antibody-M2 (anti-M2). In this case, no data suggested liver dysfunction, and subsequent liver biopsy also showed no significant pathological findings pointing to PBC. We encountered a patient with Fanconi syndrome positive for anti-M2. This case may attract interest, particularly in the mechanism of nephropathy due to anti-M2, and therefore, this case is reported with a literature review.
- Published
- 2011
32. [Case of peritubular capillary dominant intravascular large B-cell lymphoma (PTC dominant IVLBCL) successfully treated with chemotherapy].
- Author
-
Kado H, Hatta T, Ueno R, Takagi A, Segawa H, Sawada K, and Hosokawa Y
- Subjects
- Aged, Antibodies, Monoclonal, Murine-Derived administration & dosage, Antineoplastic Combined Chemotherapy Protocols administration & dosage, Cyclophosphamide administration & dosage, Cytarabine administration & dosage, Doxorubicin administration & dosage, Female, Humans, Lymphoma, Large B-Cell, Diffuse diagnosis, Prednisolone administration & dosage, Rituximab, Treatment Outcome, Vascular Neoplasms diagnosis, Vincristine administration & dosage, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Capillaries, Kidney Tubules blood supply, Lymphoma, Large B-Cell, Diffuse drug therapy, Vascular Neoplasms drug therapy
- Abstract
A 72-year-old woman developed common cold-like symptoms, diarrhea, a staggering gait, and persistent anorexia from the beginning of May 2009. In the middle of May, her general fatigue worsened, and she was transported to our hospital by ambulance. Abdominal CT showed bilateral renal enlargement, and her general condition and renal function rapidly deteriorated. The soluble interleukin-2 receptor (sIL-2R) level was elevated to 5,928 U/mL, and gallium scintigraphy showed a weak uptake in both kidneys. We considered the possibility of malignant lymphoma, and performed a renal biopsy, which showed no glomerular abnormalities, but disclosed the accumulation of large, atypical lymphoid cells with a high N/C ratio and dark chromatin in peritubular capillaries (PTC). On immunohistochemical staining, these atypical cells were found to be CD5(+), CD20 (+/-), CD10(-), CD3(-), and CD7(-), leading to a diagnosis of intravascular large B-cell lymphoma (IVLBCL). Since gallium scintigraphy showed no uptake in other organs, and examination of the cerebrospinal fluid and bone marrow revealed no tumor cells, the patient was considered to have kidney-limited IVLBCL. Chemotherapy was started immediately, which resulted in an improved general condition. Although her renal function deteriorated sufficiently to require dialysis, she was weaned from dialysis. After treatment with chemotherapy, the enlarged kidneys returned to the normal size. Subsequently, she has been receiving chemotherapy intermittently, and has remained free of recurrence. In general, IVLBCL mainly involving the kidney is difficult to diagnose antemortem, and is sometimes found at autopsy. We suggest that bilateral renal enlargement with renal failure of unknown origin should raise the suspicion of malignant lymphoma requiring a prompt renal biopsy. Cases of LBCL in which lymphoma cells fill PTC, as in this patient, have rarely been reported. We believe that this case is extremely valuable in understanding the pathogenesis of intravascular lymphoma invading the kidney; therefore, we report it with a review of the literature.
- Published
- 2011
33. [Efficacy of intravitreal bevacizumab for age-related macular degeneration].
- Author
-
Ueno C, Emi K, Sato T, Minami T, Nakatani E, Iseki R, Tanaka T, Oura Y, Sawada K, Soma T, Morita S, Sato S, Bando H, and Ikeda T
- Subjects
- Aged, Antibodies, Monoclonal, Humanized, Bevacizumab, Female, Humans, Male, Retrospective Studies, Visual Acuity, Vitreous Body, Angiogenesis Inhibitors administration & dosage, Antibodies, Monoclonal administration & dosage, Macular Degeneration drug therapy
- Abstract
Purpose: To investigate the efficacy of intravitreal bevacizumab (IVB) for neovascular age-related macular degeneration (AMD)., Methods: We conducted a retrospective study of 29 eyes of 29 patients with AMD (19 eyes) and polypoidal choroidal vasculopathy (PCV; 10 eyes), who were followed up at least 1 year after the initial IVB (1.0 mg/0.04 ml). The eyes were classified according to the lesion type and size. Best-corrected visual acuity (BCVA) and central retinal thickness were examined before and 3 months, 6 months and 12 months after the IVB., Results: The mean application times of IVB were 2.1 in 1 year. When classifying the eyes according to the lesion type, BCVA improved in 5 (26.3%) eyes with AMD and 1 (10.0%) eye with PCV by over 0.2 logarithmic minimum angle of resolution (logMAR) units. The BCVA decreased significantly 1 year after the IVB in eyes with PCV (p = 0.032). When classifying the eyes according to the lesion size, BCVA improved by over 0.2 logMAR units in the 4 (50.0%) eyes with a size of less than 1 disc diameter, 1 (10.0%) eye with the size of 1 to 3 disc diameters, and 1 (9.1%) eye with the size of over 4 disc diameters. The BCVA decreased significantly 1 year after the IVB in the eyes with the size of 1 to 3 disc diameters and with the size of over 4 disc diameters (p = 0.028, 0.013, respectively). The central retinal thickness did not change significantly at any time point compared to that before the IVB., Conclusions: These results suggest that IVB may be efficacious in preserving visual acuity in AMD eyes and in eyes with the size of less than 1 disc diameter.
- Published
- 2010
34. [Drug therapy for diabetic macular edema].
- Author
-
Sawada K
- Subjects
- Antibodies therapeutic use, Humans, Triamcinolone Acetonide therapeutic use, Vascular Endothelial Growth Factor A immunology, Diabetic Retinopathy complications, Macular Edema drug therapy
- Published
- 2010
35. [Susceptibility testing for Haemophilus influenzae isolated from pediatric cases during 2004-2008].
- Author
-
Sawada K, Sato H, Arima M, and Hoshino T
- Subjects
- Child, Haemophilus influenzae isolation & purification, Humans, Haemophilus influenzae drug effects, Microbial Sensitivity Tests
- Abstract
We tested for antimicrobial susceptibility of 1,317 clinical isolates of Haemophilus influenzae at a pediatric facility during 2004-2008. The percentage distribution of beta-lactamase-non-producing ampicillin (ABPC)-sensitive strain (BLNAS) was 47.8%, that of beta-lactamase-non-producing ABPC-resistant strain (BLNAR) 32.7% that of intermediately resistant strain (BLNAI) 8.9% that of beta-lactamase producing ABPC resistant strain (BLPAR) 6.8% and that of clavulanic acid/amoxicillin resistant strain (BLPACR) 3.7%. BLNAR prevalence was 30% between 2005 and 2008, increasing slowly. Though reduced susceptibility was seen in most beta-lactams, piperacillin and tazobactam/piperacillin showed good susceptibility for H. influenzae. Of 1,317 strains, 83 (6.3%) were serotype b (Hib). The frequency of Hib was high in sterilized site.
- Published
- 2010
- Full Text
- View/download PDF
36. [Follicle stimulating hormone (FSH)].
- Author
-
Sawada K, Kimura T, and Morishige K
- Subjects
- Child, Preschool, Female, Humans, Male, Pregnancy, Follicle Stimulating Hormone blood
- Published
- 2010
37. [QT interval shortening].
- Author
-
Taniguchi T and Sawada K
- Subjects
- Humans, Arrhythmias, Cardiac diagnosis, Arrhythmias, Cardiac drug therapy, Electrocardiography
- Published
- 2010
38. [Case of ruptured multiple cerebral aneurysms associated with primary aldosteronism].
- Author
-
Sawada K, Maehara T, Inaji M, Toriyama H, Okada T, Nariai T, Aoyagi M, Doi M, and Ohno K
- Subjects
- Adenoma complications, Adenoma surgery, Adrenal Gland Neoplasms complications, Adrenal Gland Neoplasms surgery, Adrenalectomy, Female, Humans, Middle Aged, Vascular Surgical Procedures, Aneurysm, Ruptured etiology, Aneurysm, Ruptured surgery, Hyperaldosteronism complications, Intracranial Aneurysm etiology, Intracranial Aneurysm surgery, Subarachnoid Hemorrhage etiology
- Abstract
Primary aldosteronism (PA) has been recognized as a relatively benign form of hypertension associated with a low incidence of vascular complications. Recent reports, however, indicate that cerebrovascular accidents are common in PA. We report a case of multiple aneurysms with PA in a middle-aged woman who presented with subarachnoid hemorrhage. A 47-year-old woman with a history of untreated hypertension was referred to our hospital for subarachnoid hemorrhage. Cerebral angiography showed multiple small aneurysms. The initial intervention was aneurysm clipping for a ruptured aneurysm at the bifurcation of the right middle cerebral artery. Despite medication, she continued to suffer from uncontrolled hypertension and hypokalemia. She was diagnosed with PA on the basis of elevated plasma aldosterone, suppressed plasma rennin, and a right adrenal tumor detected by abdominal CT scanning. She underwent several more neck clippings for the remaining aneurysms (unruptured), followed by a total right adrenectomy. Histological examination revealed an adrenal adenoma. After the operation, her blood pressure returned to normal without any vasodepressors. Recent studies have demonstrated that hyperaldosteronism might have direct vasculo-toxic actions, including remodeling, fibrosis, and proliferation. Cerebrovascular accidents caused by PA are reported to have high rates of mortality and recurrence when the PA is overlooked or untreated. Physicians must be alert to the possibility of PA in patients with hypertension and persistent hypokalemia, especially in those who are young or middle-aged. We also recommend screening for intracranial aneurysms by low-invasive magnetic resonance angiography.
- Published
- 2010
39. [Efficacy of treatments on vision-related quality of life in patients with diabetic retinopathy].
- Author
-
Emi K, Ikeda T, Bando H, Sato S, Morita S, Oyagi T, Sato T, Sawada K, Oura Y, and Ueno C
- Subjects
- Diabetic Retinopathy physiopathology, Female, Humans, Male, Middle Aged, Treatment Outcome, Diabetic Retinopathy surgery, Light Coagulation, Quality of Life, Vision, Ocular, Vitrectomy
- Abstract
Purpose: To evaluate changes in the vision-related quality of life in patients with diabetic retinopathy with the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25). Patients were categorized into three groups : without treatment, receiving pan-retinal photocoagulation, and those who had vitrectomy., Subjects and Methods: Altogether 327 patients (131 without treatment, [observation group]; 60 receiving pan-retinal photocoagulation, [photocoagulation group]; and 136 patients who had vitrectomy, [vitrectomy group]). The VFQ-25 was recorded at the time of entry and 1 year later. The VFQ-25 score was compared between the time of entry and 1 year later for each group and among the three groups at both the time of entry and 1 year later., Results: VFQ-25 scores (mean +/- standard deviations) at the time of entry and 1 year later were 91.3 +/- 7.8 and 92.2 +/- 7.8 in the observation group, 80.7 +/- 15.7 and 77.6 +/-19.1 in the photocoagulation group, and 67.4 +/-17.3 and 75.4 +/- 17.5 in the vitrectomy group. VFQ-25 scores in the observation group and in the photocoagulation group did not change statistically between the time of entry and 1 year later (p = 0.113, 0.169, respectively), while the score of the vitrectomy group increased statistically (p < 0.001). In addition, although VFQ-25 scores were statistically significant among the three groups at the time of entry (p < 0.05), the scores 1 year later were not statistically different between the photocoagulation group and vitrectomy group., Conclusions: These results suggest that vitrectomy for diabetic retinopathy may be effective in increasing the quality of life of patients with diabetic retinopathy.
- Published
- 2009
40. [Efficacy of vitreous surgery for uveal effusion syndrome].
- Author
-
Ohkita T, Emi K, Toyoda E, Ueno C, Sawada K, Sawada K, Matsumura N, Morita S, Kashimoto D, Oyagi T, and Ikeda T
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Retrospective Studies, Syndrome, Uveal Diseases surgery, Vitrectomy
- Abstract
Purpose: To evaluate the efficacy of pars plana vitrectomy for uveal effusion syndrome retrospectively., Subjects and Methods: Six patients (six eyes) with uveal effusion syndrome(UE) underwent vitrectomy followed by internal drainage of subretinal fluid, fluid-gas exchange, and pan-retinal photocoagulation. Three of these cases with nanophthalmos underwent silicone oil injection., Results: The retina became reattached in all cases. The silicone oil was not removed in two of the three cases with nanophthalmic eyes. Two cases of the three cases with nanophthalmic eyes needed to perform full thickness sclerostomy additionally, and in one case subchoroidal hemorrhage occurred. The visual acuity finally improved in five out of the six eyes., Conclusions: In cases of uveal effusion without nanophthalmic, vitrectomy hastens quick reattachment of the retina and may result in better visual outcome. But in cases of nanophthalmic eyes, it would be better to perform sclerostomy first.
- Published
- 2008
41. [Evaluation of the efficacy of intravitreal gas injection for submacular hemorrhages].
- Author
-
Sawada K, Ikeda T, Oyagi T, Okita T, Kashimoto D, Bando H, Morita S, Matsumura N, Sawada K, Toyoda E, Ueno C, and Emi K
- Subjects
- Aged, Aged, 80 and over, Female, Humans, Injections, Male, Middle Aged, Retrospective Studies, Sulfur Hexafluoride administration & dosage, Vitreous Body, Gases administration & dosage, Macula Lutea, Retinal Hemorrhage therapy
- Abstract
Purpose: To evaluate the efficacy of intravitreal gas injection for submacular hemorrhages(SMH)., Patients and Methods: The records of 29 patients with SMH, who were treated by pneumatic displacement with expansile gas, were reviewed retrospectively., Result: In observable cases, SMH had started moving within five days after the procedure. After 6 months visual acuity had been improved 2 or more lines in 23 eyes(79%). The causes of SMH were age-related macular degeneration (17 eyes) and microaneurysm (12 eyes). The larger the size of SMH, had the greater the risk of developing vitreous hemorrhage. Twelve eyes of the 29 eyes required vitrectomy owing to vitreous hemorrhage, insufficient removal of SMH, etc. but this pneumatic procedure often eliminated the need for vitrectomy. The visual acuity of the patients with additional vitrectomy was improved with only pneumatic displacement. None of the patients had serious complications with this pneumatic procedure and the vitrectomy., Conclusion: The first choice for SMH is intravitreal gas injection which saves foveal function, and improves the prognosis for better vision.
- Published
- 2008
42. [Aplastic anemia and pure red cell aplasia].
- Author
-
Sawada K and Hirokawa M
- Subjects
- Adrenal Cortex Hormones administration & dosage, Antilymphocyte Serum administration & dosage, Bone Marrow Transplantation, Cyclophosphamide administration & dosage, Cyclosporine administration & dosage, Drug Therapy, Combination, Granulocyte Colony-Stimulating Factor administration & dosage, Humans, Immunosuppressive Agents administration & dosage, Plasma Exchange, Severity of Illness Index, Anemia, Aplastic classification, Anemia, Aplastic diagnosis, Anemia, Aplastic therapy, Red-Cell Aplasia, Pure classification, Red-Cell Aplasia, Pure diagnosis, Red-Cell Aplasia, Pure therapy
- Abstract
Aplastic anemia (AA) is a disorder characterized by the presence of pancytopenia and a hypocellular bone marrow. Acquired pure red cell aplasia (PRCA), a part of a unique form of AA, is a rare condition of profound anemia characterized by the absence of reticulocytes and the virtual absence of erythroid precursors in the bone marrow. AA can be effectively treated by either stem cell transplantation or immunosuppressive therapy. However, PRCA has so far been treated by several different regimens which are largely empirically selected since so little control data are available. This issue focuses on the current progress in the treatment of acquired AA and PRCA.
- Published
- 2008
43. [Influence of vitrectomy for diabetic retinopathy on health-related quality of life].
- Author
-
Emi K, Oyagi T, Ikeda T, Bando H, Okita T, Kashimoto D, Morita S, Matsumura N, Sawada K, Sawada K, Toyoda E, and Ueno C
- Subjects
- Diabetic Retinopathy physiopathology, Female, Humans, Male, Middle Aged, Surveys and Questionnaires, Vision, Ocular, Diabetic Retinopathy surgery, Quality of Life, Vitrectomy
- Abstract
Purpose: To evaluate the vision-related quality of life (QOL) in patients undergoing vitrectomy for diabetic retinopathy with the Japanese version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI VFQ-25)., Subjects and Methods: Subjects were 87 patients undergoing vitrectomy for diabetic retinopathy of vitreous hemorrhage, macular edema, or fibrovascular membrane, only for the subject eye, or for subjects undergoing vitrectomy for the fellow eye within 6 months or later. The VFQ-25 date was recorded one month before and 6 months after the vitrectomy. The VFQ-25 data were compared before and after the vitrectomy. The subjects were classified by the pathological condition: 41 eyes with vitreous hemorrhage, 28 eyes with macular edema, and 18 eyes with fibrovascular membrane., Results: The average VFQ-25 scores of all the patients increased in almost all of the 12 subscales. Vitrectomy for vitreous hemorrhage was most effective in improving the VFQ-25 score, in improving 10 of the 12 subscales in the VFQ-25, and in increasing VFQ-25 scores to almost the same level as in phacoemulsification and foldable intraocular lens implantation for cataract patients in both eyes., Conclusion: NEI VFQ-25 quantitatively clarified that vitrectomy for diabetic retinopathy is effective in increasing the QOL of diabetic retinopathy patients.
- Published
- 2008
44. [Effect of occlusal form in buccal cusps of molars on masticatory function and intraoral food flow].
- Author
-
Maruyama M, Kohno S, Sawada K, Honma W, and Negishi M
- Subjects
- Adult, Food, Humans, Male, Dental Occlusion, Mastication physiology, Molar physiology
- Abstract
Purpose: The degree of crushing and intraoral food flow was evaluated using peanuts by the occlusal forms of a removable bridge as indices to clarify the occlusal formative effect of maxillary molars on masticatory function., Methods: The subject was a 29-year-old male without any gnathostomatic disorders and his removable bridge ([7] 6 [5]) was so made in interocclusal distance as to be 0.5, 1.0 or 1.5 mm from 0 mm standard having occlusal contact to antagonist. Then the subject was asked to chew 3 g of peanuts in a series of unilateral chewing schemes consisting of 5, 10, and 20 masticatory strokes each. The pool rate in the buccal oral vestibule and lingual proper oral cavity as an index of food flow was calculated as the weight of peanut particles accumulated in each side as a percentage of the total volume of recovered peanut particles. Also, the degree of crushing was calculated as the weight of peanut particles that passed through 10-mesh sieves as a percentage of the total weight in each side., Results: As the interocclusal distance to the mandibular cusp increased with abrasion on the inside at maxillary buccal cusps, the pool rate of the buccal oral vestibule was significantly increased and correspondingly that of the lingual proper oral cavity was decreased. The degree of crushing indicated non-significances statistically among 0, 0.5, and 1.0 mm and significantly decreased in 1.5 mm as compared with 0 mm., Conclusion: As the interocclusal distance to mandibular cusps from the maxillary inside of buccal cusps was increased, the pool rate of the crushed peanuts in the buccal side increased and the pool rate of crushed peanuts in the lingual side decreased, and the particles showed a comparatively low degree of crushing. It is clear that maxillary buccal occlusion has an effect on the crushing function and food flow.
- Published
- 2007
- Full Text
- View/download PDF
45. [Recovery from chronic hearing disturbance after the steroid therapy in a patient with Cogan's syndrome].
- Author
-
Togashi M, Okuyama S, Masai R, Hatakeyama T, Ohtani H, Komatsuda A, Wakui H, and Sawada K
- Subjects
- Humans, Keratitis, Male, Middle Aged, Syndrome, Hearing Loss, Bilateral drug therapy, Hearing Loss, Sensorineural drug therapy, Prednisolone therapeutic use
- Published
- 2007
- Full Text
- View/download PDF
46. [Early relapse of Burkitt's lymphoma with t(8;14) and t(14;18) after rituximab-combined CODOX-M and IVAC therapy].
- Author
-
Fujishima N, Fujishima M, Inomata M, Yamanaka Y, Saitoh K, Kameoka Y, Yoshioka T, Saitoh H, Takahashi N, Hirokawa M, and Sawada K
- Subjects
- Adult, Antibodies, Monoclonal administration & dosage, Antibodies, Monoclonal, Murine-Derived, Antineoplastic Combined Chemotherapy Protocols administration & dosage, Cyclophosphamide administration & dosage, Cytarabine administration & dosage, Disease Progression, Doxorubicin administration & dosage, Etoposide administration & dosage, Fatal Outcome, Female, Humans, Ifosfamide administration & dosage, Methotrexate administration & dosage, Recurrence, Remission Induction, Rituximab, Vincristine administration & dosage, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Burkitt Lymphoma drug therapy, Burkitt Lymphoma genetics, Chromosomes, Human, Pair 14 genetics, Chromosomes, Human, Pair 8 genetics, Translocation, Genetic genetics
- Abstract
A 43-year-old female was admitted with therapy-resistant pancreatitis and an abdominal tumor around the pancreatic head. Laboratory data revealed leukocytosis with a white blood cell count of 18200/microl, 25% atypical cells and an LDH of 13410 IU/l. The bone marrow was comprised of 78.4 percent lymphoblastoid cells which were positive for CD10, CD19 and CD20, and the cytogenetic study of which demonstrated the presence of t(8;14) (q24;q32) and t(14;18) (q32;q21) in the same clone. The patient was diagnosed as having Burkitt's lymphoma (BL) with t(8;14) and t(14;18). Although CODOX-M and IVAC therapy combined with rituximab achieved complete remission, she died of rapid progressive disease during whole brain irradiation before autologous peripheral blood stem cell transplantation. Even if the intensive chemotherapy with rituximab is given adequately, durable remission may not be achieved in BL with translocation of t(8;14) and t(14;18). A more effective therapy remains to be established for the treatment of this disease.
- Published
- 2007
47. [Diagnosis and treatment of malignant lymphoma].
- Author
-
Sawada K and Takahashi N
- Subjects
- Adult, Humans, Lymphoma diagnosis, Lymphoma therapy
- Published
- 2007
- Full Text
- View/download PDF
48. [Clinical and bacterial analysis of pediatric urinary tract infection].
- Author
-
Hoshino T, Ishiwada N, Abe K, Sawada K, and Kohno Y
- Subjects
- Adolescent, Anti-Infective Agents, Urinary therapeutic use, Child, Child, Preschool, Escherichia coli drug effects, Escherichia coli isolation & purification, Female, Humans, Infant, Klebsiella pneumoniae drug effects, Klebsiella pneumoniae isolation & purification, Male, Methicillin Resistance, Microbial Sensitivity Tests, Pseudomonas aeruginosa drug effects, Pseudomonas aeruginosa isolation & purification, Staphylococcus aureus drug effects, Staphylococcus aureus isolation & purification, Urinary Tract Infections drug therapy, Anti-Infective Agents, Urinary pharmacology, Urinary Tract Infections microbiology
- Abstract
We analyzed the clinical and bacterial backgrounds of 120 patients with pediatric urinary tract infection (UTI). Escherichia coli was the main pathogen recovered from 98 patients (81.7%). All causative agents isolated from 50 uncomplicated UTI cases were E. coli. Of 98 cases of E. coli UTI, 71 were treated with second-generation cephems, whose therapeutic effect was equal to that of third and fourth-generation cephems. MIC50 and MIC90 (microg/mL) for E. coli were as follows: cefazolin :2, 4; cefmetazole: < or = 0.5, 2; and ceftazidime: < or = 0.25, < or = 0.25. Yearly decline in susceptibility was not observed, but MIC elevation for third generation cephems (< or = 2 microg/mL) including ceftazidime was seen in six isolates. Careful monitoring of susceptibility trends is therefore necessary for appropriate antimicrobial therapy.
- Published
- 2007
- Full Text
- View/download PDF
49. [Pure red cell aplasia: clinical manifestations and treatment].
- Author
-
Sawada K
- Subjects
- Humans, Red-Cell Aplasia, Pure physiopathology, Red-Cell Aplasia, Pure therapy
- Published
- 2006
50. [Diagnostic approach. 1. When anemia is detected at the initial diagnosis].
- Author
-
Sawada K
- Subjects
- Aged, Humans, Anemia diagnosis
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.